GNRH1 and endometriosis: As recently reviewed [103], three oral GnRH antagonists, elagolix, relugolix and linzagolix, have generated robust data in the latest randomized, placebo-controlled clinical trials for treatment of endometriosis-associated pain in symptomatic premenopausal subjects.